ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,304Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 2429

$792K Total Retail Price of All Prescriptions

Rank: 91 out of 2429

377 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

18% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 13,334 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 600 522 1 1
METOPROLOL SUCCINATE 440 407 2 12
AMLODIPINE BESYLATE 419 365 3 4
LEVOTHYROXINE SODIUM 418 384 4 3
OMEPRAZOLE 360 351 5 7
METFORMIN HCL 337 275 6 8
METOPROLOL TARTRATE 323 277 7 9
NEXIUM 288 267 8 37
LISINOPRIL 274 219 9 2
HYDROCHLOROTHIAZIDE 267 217 10 10
WARFARIN SODIUM 266 251 11 11
FUROSEMIDE 262 262 12 5
ZOLPIDEM TARTRATE 244 206 13 28
ATENOLOL 244 223 13 15
LIDODERM 239 226 15 109
SPIRONOLACTONE 217 217 16 62
ISOSORBIDE MONONITRATE ER 206 204 17 55
ALENDRONATE SODIUM 183 157 18 20
ATORVASTATIN CALCIUM 177 176 19 13
HYDROCODONE-ACETAMINOPHEN 166 95 S3 20 6
IBUPROFEN 165 138 21 57
DIOVAN 165 141 21 36
NAMENDA 165 165 21 35
LOVAZA 159 135 24 134
DONEPEZIL HCL 147 147 25 26
FLUTICASONE PROPIONATE 145 121 26 39
TAMSULOSIN HCL 140 122 27 29
CRESTOR 135 112 28 25
CLOPIDOGREL 134 121 29 31
JANUVIA 128 102 30 66
CREON 114 95 31 332
ESCITALOPRAM OXALATE 114 109 31 74
LOSARTAN-HYDROCHLOROTHIAZIDE 106 98 33 73
TRAMADOL HCL 105 92 34 17
DIOVAN HCT 104 101 35 83
PANTOPRAZOLE SODIUM 104 98 35 34
LOSARTAN POTASSIUM 104 88 35 22
FAMOTIDINE 103 90 38 42
ENALAPRIL MALEATE 103 93 38 32
BENAZEPRIL HCL 99 97 40 80
AMLODIPINE BESYLATE-BENAZEPRIL 97 97 41 85
PLAVIX 97 91 41 44
HYDRALAZINE HCL 96 70 43 81
NITROGLYCERIN PATCH 94 94 44 155
QUETIAPINE FUMARATE 93 80 45 77
POLYETHYLENE GLYCOL 3350 92 92 46 56
VERAPAMIL ER 91 91 47 115
GABAPENTIN 91 73 47 18
CARVEDILOL 88 84 49 21
POTASSIUM CHLORIDE 86 82 50 14
DIGOXIN 83 73 51 43
MECLIZINE HCL 82 74 52 131
NAPROXEN 80 72 53 75
TRIAMCINOLONE ACETONIDE 78 65 54 99
GLIPIZIDE 77 76 55 47
GLYBURIDE 77 51 R 55 64
AZITHROMYCIN 77 52 55 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 75 58 27
PROPRANOLOL HCL 74 62 59 119
INSULIN SYRINGE 74 68 59 90
CITALOPRAM HBR 73 47 61 19
PROAIR HFA 71 47 62 41
NITROSTAT 70 68 63 265
TRIAMTERENE-HCTZ 68 68 64 53
CIPROFLOXACIN HCL 67 59 65 84
DICLOFENAC SODIUM 66 36 66 103
ZETIA 65 63 67 70
MIRTAZAPINE 63 62 68 63
ADVAIR DISKUS 63 46 68 49
GLIMEPIRIDE 60 47 70 51
PROCTOSOL-HC 59 58 71 469
LANTUS 58 55 72 45
VOLTAREN 57 42 73 190
METHYLPREDNISOLONE 57 11 73 144
LOVASTATIN 57 49 73 30
ZENPEP 56 39 76 281
SERTRALINE HCL 55 38 77 23
RANITIDINE HCL 55 32 77 24
CLOBETASOL PROPIONATE 55 51 77 301
PAROXETINE HCL 53 31 80 67
CLONIDINE HCL 53 52 80 68
LEVOTHROID 53 40 80 281
BENICAR HCT 51 29 83 241
VESICARE 50 48 84 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.